In situ expression of Th17 immunologic mediators in American cutaneous leishmaniasis caused by Leishmania (V.) braziliensis and Leishmania (L.) amazonensis in the Brazilian Amazon

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
BARROS, J. P. B.
LIMA, A. C. S. de
CAMPOS, M. B.
MORAES, C.
Citação
FRONTIERS IN TROPICAL DISEASES, v.4, article ID 1067595, p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
American cutaneous leishmaniasis (ACL) presents a wide spectrum of clinical and immunopathological manifestations. In Brazil, Leishmania (L.) amazonensis[La] and Leishmania(V.)braziliensis[Lb] show the highest pathogenic potential for humans causing different clinical forms: localized cutaneous leishmaniasis (LCL : Lb/La), anergic diffuse cutaneous leishmaniasis (ADCL : La) and mucocutaneous leishmaniasis (MCL : Lb). ADCL and MCL are the most severe forms and infection leads to a cellular immune response at the hyposensitivity and hypersensitivity poles. Th17-cells are involved in the ACL pathogenesis, are derived from naïve TCD4+ cells regulated by RORγt, differentiate in presence of IL-6, TGF-β, IL- 1β, IL-23 and express IL-17. Aim of this study was to characterize the cellular immune response mediated by Th17-profile cells through in situ determination of the expression of RORγt, IL-17, IL-6, TGF-β, IL-1β, and IL-23 in the ACL clinical-immunopathological spectrum caused by L.(L.)amazonensis and L.(V.)braziliensis. Biopsies of skin and mucosal lesions from forty patients including ADCL(n=8), LCL[La](n=17), LCL[Lb](n=9) and MCL(n=6), were examined by immunohistochemistry. The immunostained cells density (cells/mm2) was determined in image analysis system using AxionVision 4.8 software (Zeiss). As the disease evolution time (DET) was different among ACL patients, the effect of DET on the expression of immunological markers was evaluated in different clinical forms and histopathological changes, using ANCOVA. Our results showed significantly increased expression of RORγt, IL-17, IL-6, IL-1β and IL-23 in patients with ACL polar forms (ADCL and MCL); higher TGF-β expression was found in ADCL. DET influenced the expression of RORγt and IL-6 in: clinical forms of ACL and in categories of parasitism. DET also affected the production of RORγt, IL-17, IL-6, TGF-β and IL-1β in types of inflammatory infiltrate, evidencing that DET had effect on the expression of Th17 profile cytokines in ACL. Together, the expression of immunological mediators of Th17 profile in the ACL spectrum, as well as the DET effect, demonstrate the participation of this cell lineage in the immunopathogenesis of ACL, mainly in the polar and more severe forms of ACL spectrum. The dubious role played by Th17-cells may favors immune response suppression and parasitic persistence in ADCL, while in MCL it contributes to an exacerbated immune response and parasite scarcity.
Palavras-chave
American cutaneous leishmaniasis, cellular immunity, immunohistochemistry, leishmania (V.) braziliensis, leishmania(L.)amazonensis, Th17-cells
URI
https://observatorio.fm.usp.br/handle/OPI/58641
Referências
  1. Espinosa O.A., Serrano M.G., Camargo E.P., Teixeira M.M.G., Shaw J.J., An appraisal of the taxonomy and nomenclature of trypanosomatids presently classified as leishmania and Endotrypanum, Parasitology, 145, 4, (2018)
  2. Dados notificados pelos programas nacionais de Leishmanioses/Serviços de vigilância, Disponível Em, 5, (2022)
  3. Campos M.B., De Castro Gomes C.M., de Souza A.A., Lainson R., Corbett C.E., Silveira F.T., In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis, Parasitol Res, 103, 4, (2008)
  4. Silveira F.T., Lainson R., Corbett C.E., Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian brasil – a review, Mem Inst Oswaldo Cruz, 99, 3, (2004)
  5. Silveira F.T., What makes mucosal and anergic diffuse cutaneous leishmaniases clinically and immunopathogically different? A review in Brazil, Trans R Soc Trop Med Hyg, 29, (2019)
  6. Costa J.M.L., Et al., Leishmaniose cutânea difusa (Lcd) no brasil após 60 anos de sua primeira descrição, Gazeta Médica Da Bahia, 79, 3, (2009)
  7. Silveira F.T., Muller S.R., De Souza A.A.A., Lainson R., Gomes C.M.C., Laurenti M.D., Et al., Revisão sobre a patogenia da leishmaniose tegumentar Americana Na amazônia, com Ênfase À doença causada por Leishmania (V.) braziliensis e L. (L.) Amazonensis, Rev Paraense Medicina Pará, 22, pp. 9-20, (2008)
  8. Sacks D., Noben-Trauth N., The immunology of susceptibility and resistance to leishmania major in mice, Nat Rev Immunol, 2, (2002)
  9. Maspi N., Abdoli A., Ghaffarifar F., Pro and anti-inflammatory cytokines in cutaneous leishmaniasis: A review, Pathog Glob Health, 110, 6, (2016)
  10. Gonzalez Carrion K., Caracterização das alterações histopatológicas e da resposta imune celular em lesões de Pele de pacientes com leishmaniose cutânea no panamá [Tese], (2020)
  11. Goncalves-De-Albuquerque S., Pessoa-E-Silva R., Trajano-Silva L., De Goes T., De Morais R., Da C Oliveira C., Et al., The equivocal role of Th17 cells and neutrophils on immunopathogenesis of leishmaniasis, Front Immunol, 8, (2017)
  12. Castro G., Liu X., Ngo K., De Leon-Tabaldo A., Zhao S., Luna-Roman R., Et al., Rorγt and rorα signature genes in human Th17 cells, PloS One, 12, 8, (2017)
  13. Dong C., Th17 cells in development: An updated view of their molecular identity and genetic programming, Nat Rev Immunol, 8, 5, (2008)
  14. Dong C., Differentiation and function of pro-inflammatory Th17 cells, Microbes Infect, 11, 5, (2009)
  15. Peters A., Lee Y., Kuchroo V., The many faces of Th17 cells, Curr Opin Immunol, 23, 6, (2011)
  16. Veldhoen M., Hocking R., Atkins C., Locksley R., Stockinger B., Tgf beta in the context of an inflammatory cytokine milieu supports De Novo differentiation of il-17-Producing T cells, Immunity, 24, 2, (2006)
  17. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., Et al., Generation of pathogenic Th17 cells in the absence of TGF-β signalling, Nature, 467, 7318, (2010)
  18. Jin W., Dong C., Il-17 cytokines in immunity and inflammation, Emerg Microbes Infect, 2, 9, (2013)
  19. Espir T., Figueira L.P., Naiff M.F., Da Costa A., Ramalho-Ortigao M., Malheiro A., Et al., Role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas state, Brazil, The J Immunol Res, 2014, (2014)
  20. Bacellar O., Faria D., Nascimento M., Cardoso T., Gollob K., Dutra W., Et al., Interleukin 17 production among patients with American cutaneous leishmaniasis, J Infect Dis, 200, 1, (2009)
  21. Martins V., Silva F., Caixeta F., Carneiro M., Go-es G., Torres L., Et al., Obesity impairs resistance to leishmania major infection in C57bl/6 mice, PloS Negl Trop Dis, 14, 1, (2020)
  22. Sousa L., Carneiro M., Resende M., Martins L., Dos Santos L., Vaz L., Et al., Neutrophils have a protective role during early stages of Leishmania amazonensis infection in Balb/C mice, Parasite Immunol, 36, 1, pp. 13-31, (2014)
  23. Shen J., Sun X., Pan B., Cao S., Cao J., Che D., Et al., Il-17 induces macrophages to M2-like phenotype Via nf-κb, Cancer Manag Res, 10, (2018)
  24. Graca G., Volpini A., Romero G., Oliveira Neto M., Hueb M., Porrozzi R., Et al., Development and validation of pcr-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species, Mem Inst Oswaldo Cruz, 107, 5, (2012)
  25. Menezes J., Expressão de Foxp3, il-17 e il-23 Na leishmaniose tegumentar Americana causada por Leishmania (Leishmania) amazonensis e Leishmania (Viannia) braziliensis, Dissertação (Mestrado), (2013)
  26. Flores G., Sandoval Pacheco C., Sosa Ochoa W., Gomes C., Zuniga C., Corbett C., Et al., Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania L. Infantum Chagasi in central America, Parasite Immunol, 42, 11, (2020)
  27. Gonzalez K., Calzada J., Corbett C., Saldana A., Laurenti M., Involvement of the inflammasome and Th17 cells in skin lesions of human cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis, Mediators Inflamm, 27, (2020)
  28. Laurenti M., Sosa-Ochoa W., Araujo Flores G., Sandoval Pacheco C., Tomokane T., Oliveira L., Et al., Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) Infantum Chagasi, Parasite Immunol, 44, 1-2, (2022)
  29. Boaventura V., Santos C., Cardoso C., De Andrade J., Dos Santos W., Clarencio J., Et al., Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines, Eur J Immunol, 40, 10, (2010)
  30. Costa D., Rocha R., Carvalho R., Lima-Neto A., Harhay M., Costa C., Et al., Serum cytokines associated with severity and complications of kala- azar, Pathog Glob Health, 107, 2, pp. 78-87, (2013)
  31. Sandoval Pacheco C., Araujo Flores G., Gonzalez K., De Castro Gomes C., Passero L., Tomokane T., Et al., Macrophage polarization in the skin lesion caused by Neotropical species of Leishmania sp, J Immunol Res, 2021, (2021)
  32. Carneiro F., De Magalhaes A., De Jesus Abreu Almeida Couto M., Bocca A., Muniz-Junqueira M., Ribeiro Sampaio R., Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis, Parasite Immunol, 31, 10, (2009)
  33. Fernandez-Figueroa E., Rangel-Escareno C., Espinosa-Mateos V., Carrillo-Sanchez K., Salaiza-Suazo N., Carrada-Figueroa G., Et al., Disease severity in patients infected with Leishmania mexicana relates to IL-1β, PloS Negl Trop Dos, 6, 5, (2012)
  34. Novais F., Carvalho A., Clark M., Carvalho L., Beiting D., Brodsky I., Et al., Cd8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and il-1β production, PloS Pathog, 13, 2, (2017)
  35. Saha A., Souravi R., Ukil A., Cytokines and signaling networks regulating disease outcomes in leishmaniasis, Infect Immun, 90, 8, (2022)
  36. Gomes A.H.S., Martines R.B., Kanamura C.T., Barbo M., Iglezias S.D., Lindoso J.A.L., Et al., American Cutaneous leishmaniasis: In situ imune response of patients with recent and late lesions, Parasite Immunol, 39, 4, (2017)

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/50